COX-2s Put Pfizer, Drug Companies on Shaky Ground

Another sign this movement we've started to replace the current health care paradigm -- one that's addicted to drugs and short-term "cures" -- for a more rational model based on treating the true cause of disease is picking up steam: Concerns on Wall Street that profits for Pfizer, the nation's top drugmaker, and its cohorts seem to be taking a downward slide. Specifically, the debatable "safety" of COX-2 inhibitors, Bextra and Celebrex, may indeed be placing the future of the...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports